日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Therapeutic Reprogramming of Glioblastoma Phenotypic States Using Multifunctional Heparin Nanoparticles

利用多功能肝素纳米颗粒对胶质母细胞瘤表型状态进行治疗性重编程

Le Joncour, Vadim; Evans, Austin D; Bergström, Camilla Karoliina; Rangasami, Vignesh Kumar; Samanta, Sumanta; Krishnan, Nithiyanandan; Teramura, Yuji; Nilsson, Bo; Hedenqvist, Patricia; Manell, Elin; Hilborn, Jons; Waern, Marianne-Jensen; Varghese, Oommen P; Laakkonen, Pirjo; Oommen, Oommen P

Combining an anti-HER2 antibody-drug conjugate with an anti-nectin-4 antibody-drug conjugate enhances efficacy in breast cancer and gastric cancer models.

将抗 HER2 抗体药物偶联物与抗 nectin-4 抗体药物偶联物结合,可增强乳腺癌和胃癌模型的疗效。

Yazdi Narjes, Pourjamal Negar, Li Hao, Laakkonen Pirjo, Joensuu Heikki, Barok Mark

Utilizing Monocarboxylate Transporter 1-Mediated Blood-Brain Barrier Penetration for Glioblastoma Positron Emission Tomography Imaging with 6-[(18)F]Fluoronicotinic Acid.

利用单羧酸转运体 1 介导的血脑屏障穿透进行胶质母细胞瘤正电子发射断层扫描成像,使用 6-[(18)F]氟烟酸

Dillemuth Pyry, Ayo Abiodun, Airenne Tomi T, Lövdahl Petter, Bakay Emel, Zhuang Xiaoqing, Liljenbäck Heidi, Paunonen Sami Tuomas, Kunnas Jonne, Filppu Pauliina, Rajander Johan, Johnson Mark S, Roivainen Anne, Salminen Tiina A, Rosenholm Jessica M, Laakkonen Pirjo, Li Xiang-Guo

Disitamab vedotin in preclinical models of HER2-positive breast and gastric cancers resistant to trastuzumab emtansine and trastuzumab deruxtecan

在对曲妥珠单抗-美坦新和曲妥珠单抗-德鲁替康耐药的HER2阳性乳腺癌和胃癌的临床前模型中,Disitamab vedotin显示出疗效。

Pourjamal, Negar; Le Joncour, Vadim; Vereb, György; Honkamaki, Cilla; Isola, Jorma; Leyton, Jeffrey V; Laakkonen, Pirjo; Joensuu, Heikki; Barok, Mark

Deciphering the Dialogue between Brain Tumors, Neurons, and Astrocytes

解读脑肿瘤、神经元和星形胶质细胞之间的对话

Westerlund, Leevi H; Bergström, Camilla K; Laakkonen, Pirjo M; Le Joncour, Vadim

Rapid cleavage of 6-[(18)F]fluoronicotinic acid prosthetic group governs BT12 glioblastoma xenograft uptake: implications for radiolabeling design of biomolecules.

6-[(18)F]氟烟酸前体基团的快速裂解控制着BT12胶质母细胞瘤异种移植的摄取:对生物分子放射性标记设计的影响

Dillemuth Pyry, Ayo Abiodun, Zhuang Xiaoqing, Lövdahl Petter, Liljenbäck Heidi, Kärnä Salli, Auchynnikava Tatsiana, Kunnas Jonne, Ponkamo Jesse, Miner Maxwell W G, Rajander Johan, Rosenholm Jessica M, Roivainen Anne, Airaksinen Anu J, Laakkonen Pirjo, Li Xiang-Guo

IGSF3 tissue expression in squamous cell carcinoma of the oropharynx: a novel tool for prognosis assessment in HPV-related and HPV-unrelated disease

IGSF3在口咽鳞状细胞癌中的组织表达:一种用于HPV相关和非HPV相关疾病预后评估的新工具

Sjöblom, Anni; Jouhi, Lauri; Laakkonen, Pirjo; Randén-Brady, Reija; Tarkkanen, Jussi; Haglund, Caj; Mattila, Petri; Carpén, Timo; Hagström, Jaana; Mäkitie, Antti

Peptide-Based Strategies for Targeted Tumor Treatment and Imaging

基于肽的靶向肿瘤治疗和成像策略

Ayo, Abiodun; Laakkonen, Pirjo

Motility of glioblastoma cells is driven by netrin-1 induced gain of stemness

胶质母细胞瘤细胞的运动性是由netrin-1诱导的干性获得驱动的。

Ylivinkka, Irene; Sihto, Harri; Tynninen, Olli; Hu, Yizhou; Laakso, Aki; Kivisaari, Riku; Laakkonen, Pirjo; Keski-Oja, Jorma; Hyytiäinen, Marko

Metastasis-associated cell surface oncoproteomics

转移相关细胞表面癌蛋白组学

Karhemo, Piia-Riitta; Hyvönen, Maija; Laakkonen, Pirjo